BPZ-303

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBPZ-303
Drug Alias NameBPZ-303
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCapillary Leak Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioPhyZica Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioPhyZica Inc
Active IndicationsN/A
Inactive IndicationsCapillary Leak Syndrome

Other Information

ATC CodeN/A
Related LinksN/A